ELDN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Eledon Pharmaceuticals Inc (ELDN) is not a strong buy for a beginner investor with a long-term strategy at this time. While hedge funds are increasing their positions, the company's financial performance is poor, with significant losses in net income and EPS. Additionally, technical indicators and options data do not suggest a strong bullish sentiment or immediate upside potential.
The MACD is below 0 and negatively contracting, indicating weak momentum. RSI is neutral at 60.941, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 3.133), suggesting limited short-term upside. Historical stock trends predict a slight decline in the next day, week, and month.
Hedge funds have increased their buying activity by 138.83% over the last quarter. Moving averages are bullish, indicating some positive momentum.
The company's financial performance is significantly negative, with net income and EPS dropping sharply YoY. No recent news or significant insider trading activity to drive the stock higher. Historical stock trends suggest a decline in the short term.
In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -$10.45 million (-141.95% YoY), and EPS fell to -0.11 (-130.56% YoY). Gross margin remains at 0, indicating no profitability.
No recent analyst ratings or price target changes are available for ELDN.
